Alissa A. Chackerian

2.0k total citations
17 papers, 1.6k citations indexed

About

Alissa A. Chackerian is a scholar working on Immunology, Oncology and Infectious Diseases. According to data from OpenAlex, Alissa A. Chackerian has authored 17 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Oncology and 5 papers in Infectious Diseases. Recurrent topics in Alissa A. Chackerian's work include Cancer Immunotherapy and Biomarkers (6 papers), Tuberculosis Research and Epidemiology (4 papers) and CAR-T cell therapy research (4 papers). Alissa A. Chackerian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (6 papers), Tuberculosis Research and Epidemiology (4 papers) and CAR-T cell therapy research (4 papers). Alissa A. Chackerian collaborates with scholars based in United States, Japan and Italy. Alissa A. Chackerian's co-authors include Samuel M. Behar, Robert A. Kastelein, Elizabeth R. Oldham, Erin E. Murphy, Stefan Pflanz, Jochen Schmitz, Christopher C. Dascher, Jennifer Alt, Edward P. Bowman and Anandi Sawant and has published in prestigious journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Alissa A. Chackerian

16 papers receiving 1.6k citations

Peers

Alissa A. Chackerian

IMMUN

EPIDE

SURGE

ONCOL

Cheng‐Lung Ku Taiwan

Annalisa Azzurri Italy

Domenico Galati Italy

Sergio Arce United States

Ahmet Elmaağaclı Germany

Manuel Muro Spain

Ulrich R. Foelsch Germany

Matthew J. Lindemann United States

Esperanza Anguiano United States

Yumiko Sugawara Japan

Cheng‐Lung Ku Taiwan

Alissa A. Chackerian

1.0k ×0.9

IMMUN

339 ×0.7

614 ×1.5

EPIDE

159 ×0.4

SURGE

133 ×0.5

ONCOL

Citations per year, relative to Alissa A. Chackerian Alissa A. Chackerian (= 1×) peers Cheng‐Lung Ku

Countries citing papers authored by Alissa A. Chackerian

Since Specialization

Citations

This map shows the geographic impact of Alissa A. Chackerian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alissa A. Chackerian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alissa A. Chackerian more than expected).

Fields of papers citing papers by Alissa A. Chackerian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alissa A. Chackerian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alissa A. Chackerian. The network helps show where Alissa A. Chackerian may publish in the future.

Co-authorship network of co-authors of Alissa A. Chackerian

This figure shows the co-authorship network connecting the top 25 collaborators of Alissa A. Chackerian. A scholar is included among the top collaborators of Alissa A. Chackerian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alissa A. Chackerian. Alissa A. Chackerian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Tran, Thai Q., Jeff Grein, Mohammed Selman, et al.. (2024). Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer. SHILAP Revista de lepidopterología. 32(2). 200807–200807. 1 indexed citations

Tan, Tze Guan, Aleksandra Olow, Michael T. Wong, et al.. (2022). SPATA2 and CYLD inhibit T cell infiltration into colorectal cancer via regulation of IFN-γ/STAT1 axis. Frontiers in Oncology. 12. 1016307–1016307.

Raghavan, Sukanya, Christina M. Kochel, Anandi Sawant, et al.. (2021). Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor Efficacy. Frontiers in Immunology. 12. 752348–752348. 3 indexed citations

Bauché, David, Smita Mauze, Christina M. Kochel, et al.. (2020). Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions. Journal for ImmunoTherapy of Cancer. 8(2). e001584–e001584. 21 indexed citations

Wiswell, Derek, Edward P. Bowman, Douglas E. Linn, et al.. (2020). A capillary electrophoresis based approach for the identification of anti-drug antibodies against camelid VHH biologics (Nanobodies®). Journal of Pharmacological and Toxicological Methods. 103. 106872–106872. 8 indexed citations

Perets, Ruth, Jair Bar, Drew Rasco, et al.. (2020). Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer. Annals of Oncology. 32(3). 395–403. 65 indexed citations

Hossain, Dewan Md Sakib, Sarah Javaid, Mingmei Cai, et al.. (2018). Dinaciclib induces immunogenic cell death and enhances anti-PD1–mediated tumor suppression. Journal of Clinical Investigation. 128(2). 644–654. 167 indexed citations

Ugarte, Fernando, Anandi Sawant, Mingmei Cai, et al.. (2016). Abstract 562: Dinaciclib induces immunogenic cell death and enhances anti-PD-1 mediated tumor suppression. Cancer Research. 76(14_Supplement). 562–562. 1 indexed citations

Köhler, Gabriele, Nicole Schütze, Jens Knauer, et al.. (2008). Protective Immunity to Systemic Infection with Attenuated Salmonella enterica serovar Enteritidis in the Absence of IL-12 Is Associated with IL-23-Dependent IL-22, but Not IL-17. The Journal of Immunology. 181(11). 7891–7901. 95 indexed citations

10.

Chackerian, Alissa A., Elizabeth R. Oldham, Erin E. Murphy, et al.. (2007). IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex. The Journal of Immunology. 179(4). 2551–2555. 427 indexed citations

11.

Ghosh, Shamik, Alissa A. Chackerian, Christina M. Parker, Christie M. Ballantyne, & Samuel M. Behar. (2006). The LFA-1 Adhesion Molecule Is Required for Protective Immunity during Pulmonary Mycobacterium tuberculosis Infection. The Journal of Immunology. 176(8). 4914–4922. 43 indexed citations

12.

Bowman, Edward P., Alissa A. Chackerian, & J. Daniel. (2006). Rationale and safety of anti-interleukin-23 and anti-interleukin-17A therapy. Current Opinion in Infectious Diseases. 19(3). 245–252. 47 indexed citations

13.

Chackerian, Alissa A., Shi‐Juan Chen, Scott J. Brodie, et al.. (2006). Neutralization or Absence of the Interleukin-23 Pathway Does Not Compromise Immunity to Mycobacterial Infection. Infection and Immunity. 74(11). 6092–6099. 55 indexed citations

14.

Chackerian, Alissa A. & Samuel M. Behar. (2003). Susceptibility to Mycobacterium tuberculosis: lessons from inbred strains of mice. Tuberculosis. 83(5). 279–285. 49 indexed citations

15.

Chackerian, Alissa A., et al.. (2002). Dissemination ofMycobacterium tuberculosisIs Influenced by Host Factors and Precedes the Initiation of T-Cell Immunity. Infection and Immunity. 70(8). 4501–4509. 315 indexed citations

16.

Chackerian, Alissa A., et al.. (2002). Activation of NKT Cells Protects Mice from Tuberculosis. Infection and Immunity. 70(11). 6302–6309. 153 indexed citations

17.

Chackerian, Alissa A., et al.. (2001). Gamma Interferon-Producing CD4⁺T Lymphocytes in the Lung Correlate with Resistance to Infection withMycobacterium tuberculosis. Infection and Immunity. 69(4). 2666–2674. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact